Alison Curnow
Overview
Explore the profile of Alison Curnow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reburn C, Gawthorpe G, Perry A, Wood M, Curnow A
Pharmaceutics
. 2023 Dec;
15(12).
PMID: 38140009
(1) Background: The protoporphyrin IX (PpIX)-mediated fluorescence-guided resection and interoperative photodynamic therapy (PDT) of remaining cells may be effective adjuvants to the resection of glioma. Both processes may be enhanced...
2.
Magnussen A, Reburn C, Perry A, Wood M, Curnow A
Lasers Med Sci
. 2021 Jul;
37(2):1155-1166.
PMID: 34218351
Photodynamic therapy (PDT) is an oxygen-dependent, light-activated, and locally destructive drug treatment of cancer. Protoporphyrin IX (PpIX)-induced PDT exploits cancer cells' own innate heme biosynthesis to hyper-accumulate the naturally fluorescent...
3.
Jeynes J, Wordingham F, Moran L, Curnow A, Harries T
Biomolecules
. 2019 Aug;
9(8).
PMID: 31387293
Photothermal therapy using nanoparticles is a promising new approach for the treatment of cancer. The principle is to utilise plasmonic nanoparticle light interaction for efficient heat conversion. However, there are...
4.
Tyrrell J, Paterson C, Curnow A
Cancers (Basel)
. 2019 Jan;
11(1).
PMID: 30634715
Photodynamic therapy (PDT) is a light activated drug therapy that can be used to treat a number of dermatological cancers and precancers. Improvement of efficacy is required to widen its...
5.
Curnow A, Perry A, Wood M
Photodiagnosis Photodyn Ther
. 2018 Dec;
25:157-165.
PMID: 30553949
Background: Photodynamic therapy (PDT) is a light activated drug therapy that can be used to treat a number of cancers and precancers. It is particularly useful in its topical form...
6.
Ferguson D, Smerdon G, Harries L, Dodd N, Murphy M, Curnow A, et al.
Free Radic Biol Med
. 2018 Aug;
126:322-333.
PMID: 30142453
In vivo, mammalian cells reside in an environment of 0.5-10% O (depending on the tissue location within the body), whilst standard in vitro cell culture is carried out under room...
7.
Anayo L, Magnussen A, Perry A, Wood M, Curnow A
Lasers Surg Med
. 2018 Apr;
50(5):552-565.
PMID: 29603761
Objectives: Non-melanoma skin cancers are the most frequently occurring type of cancer worldwide. They can be effectively treated using topical dermatological photodynamic therapy (PDT) employing protoporphyrin IX (PpIX) as the...
8.
Yeo N, White M, Ronan N, Whinney D, Curnow A, Tyrrell J
Otol Neurotol
. 2017 Oct;
39(1):73-81.
PMID: 29065087
Hypothesis: Stress and unusual events are associated with a higher likelihood of attacks and increased symptom severity in Menière's disease (MD). Background: MD is an unpredictable condition which severely impacts...
9.
Dogra Y, Ferguson D, Dodd N, Smerdon G, Curnow A, Winyard P
Redox Biol
. 2016 Jul;
9:90-99.
PMID: 27454766
Methyl-aminolevulinate-based photodynamic therapy (MAL-PDT) is utilised clinically for the treatment of non-melanoma skin cancers and pre-cancers and the hydroxypyridinone iron chelator, CP94, has successfully been demonstrated to increase MAL-PDT efficacy...
10.
Curnow A, Owen S
Oxid Med Cell Longev
. 2016 Mar;
2016:7053897.
PMID: 26953144
As lifetime exposure to ultraviolet (UV) radiation has risen, the deleterious effects have also become more apparent. Numerous sunscreen and skincare products have therefore been developed to help reduce the...